ePharm5®
 
2/23/2018
Subscribe Contact Us About ePharm
 
Top Stories
 
 
1. Patients unsure about AI in their healthcare
Research from Syneos Health Communications reveals that excitement over healthcare artificial intelligence (AI) in the scientific and investor communities doesn't necessarily translate into enthusiasm from patients and caregivers. ePharm Brief
 
 
 
2. Eli Lilly survey spotlights migraine pain
A new Eli Lilly–sponsored survey found that people diagnosed with migraine experienced on average 15.4 completely pain-free days over the previous 30 days. ePharm Brief
 
 
 
3. Boston Children's Hospital joins TriNetX global health research network
Boston Children's Hospital has joined the TriNetX global health research network to further its efforts at bringing a more data-driven approach to clinical research. ePharm Brief
 
 
 
4. Albertsons Companies, Rite Aid to merge
Albertsons Companies and Rite Aid Corporation have announced a definitive merger agreement under which privately held Albertsons Companies will merge with publicly traded Rite Aid. ePharm Brief
 
 
 
5. PhRMA report touts in-development heart disease drugs
A new PhRMA report shows there are currently 200 cardiovascular medicines in development in the United States by America's biopharmaceutical companies, including 42 for heart failure, 23 for stroke, and 14 for hypertension or high blood pressure. ePharm Brief
 
 
HCPro, Inc. Privacy Statement / Terms of Use
Copyright © 2018 All Rights Reserved, ePharmaceuticals™, A Division of HCPro, Inc.
 
Yesterday's Top Stories
1. Electronic prior authorization gaining steam
2. Cedars-Sinai working on 'patient-on-a-chip' program
3. Years of healthy obesity increase heart disease risk
4. Oncology service charges vary widely
5. Blacks with AF have higher stroke risk than whites